Kohjin Bio Co., Ltd. (TYO:177A)
Japan · Delayed Price · Currency is JPY 1,402.00
-66.00 (-4.50%)
May 12, 2026, 3:30 PM JST
Kohjin Bio Market Cap
Kohjin Bio has a market cap or net worth of 7.17 billion as of May 12, 2026. Its market cap has decreased by -12.38% in one year.
Market Cap
7.17B
Enterprise Value
6.81B
Revenue
5.07B
Ranking
n/a
PE Ratio
12.87
Stock Price
1,402.00
Market Cap Chart
Since April 25, 2024, Kohjin Bio's market cap has decreased from 11.89B to 7.17B, a decrease of -39.70%. That is a compound annual growth rate of -21.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 7.17B | -5.84% |
| Dec 30, 2025 | 7.61B | -11.16% |
| Dec 30, 2024 | 8.57B | -27.92% |
| Apr 25, 2024 | 11.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OncoTherapy Science | 8.06B |
| MEDINET | 7.77B |
| StemCell Institute | 7.48B |
| BrightPath Biotherapeutics | 7.30B |
| ADR120S | 7.25B |
| CellSource | 7.18B |
| Chiome Bioscience | 6.90B |
| Soiken Holdings | 6.64B |